The Effect of Race and Shear Stress on CRP-Induced Responses in Endothelial Cells

Mediators Inflamm. 2021 Dec 2:2021:6687250. doi: 10.1155/2021/6687250. eCollection 2021.

Abstract

Background: C-reactive protein (CRP) is an independent biomarker of systemic inflammation and a predictor of future cardiovascular disease (CVD). More than just a pure bystander, CRP directly interacts with endothelial cells to decrease endothelial nitric oxide synthase (eNOS) expression and bioactivity, decrease nitric oxide (NO) production, and increase the release of vasoconstrictors and adhesion molecules. Race is significantly associated with CRP levels and CVD risks. With aerobic exercise, the vessel wall is exposed to chronic high laminar shear stress (HiLSS) that shifts the endothelium phenotype towards an anti-inflammatory, antioxidant, antiapoptotic, and antiproliferative environment. Thus, the purpose of this study was to assess the racial differences concerning the CRP-induced effects in endothelial cells and the potential role of HiLSS in mitigating these differences.

Methods: Human umbilical vein endothelial cells (HUVECs) from four African American (AA) and four Caucasian (CA) donors were cultured and incubated under the following conditions: (1) static control, (2) CRP (10 μg/mL, 24 hours), (3) CRP receptor (FcγRIIB) inhibitor followed by CRP stimulation, (4) HiLSS (20 dyne/cm2, 24 hours), and (5) HiLSS followed by CRP stimulation.

Results: AA HUVECs had significantly higher FcγRIIB receptor expression under both basal and CRP incubation conditions. Blocking FcγRIIB receptor significantly attenuated the CRP-induced decrements in eNOS expression only in AA HUVECs. Finally, HiLSS significantly counteracted CRP-induced effects.

Conclusion: Understanding potential racial differences in endothelial function is important to improve CVD prevention. Our results shed light on FcγRIIB receptor as a potential contributor to racial differences in endothelial function in AA.

MeSH terms

  • Black or African American
  • C-Reactive Protein / pharmacology*
  • Cardiovascular Diseases / prevention & control
  • Cells, Cultured
  • Human Umbilical Vein Endothelial Cells / drug effects*
  • Human Umbilical Vein Endothelial Cells / physiology
  • Humans
  • Nitric Oxide Synthase Type III / biosynthesis
  • Receptors, IgG / analysis
  • Receptors, IgG / physiology
  • Stress, Mechanical
  • White People

Substances

  • FCGR2B protein, human
  • Receptors, IgG
  • C-Reactive Protein
  • NOS3 protein, human
  • Nitric Oxide Synthase Type III